AlphAIAlphAI — Financial news for AI agents
investing.com$HUM

Humana beats estimates on earnings and revenue, raises guidance

Humana Inc. (HUM) reported Q3 earnings with an adjusted loss of -$0.70 per share, beating estimates of -$1.00. Revenue was $41.16 billion, up 26% YoY. The company raised its fiscal 2026 adjusted EPS guidance to at least $9.50. Shares slipped 0.8% post-announcement.

Original reporting
investing.com
Published Nov 6, 2026, 11:49 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 12:00 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefEarnings
Primary signal
$HUM
Bullish
high confidence
Mentioned
$HUM
Relevance
8/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$HUMBullishHigh
01

Why it matters

The earnings beat and guidance raise expectations for profit growth, likely influencing analyst forecasts and investor positioning.

02

Market read

First‑report earnings and guidance lift for a large‑cap insurer, providing fresh trading signals.

03

What to watch

Potential headwinds from rising medical cost inflation could temper long‑term upside.

Relevance 8/10Novelty 8/10Timing: after-hours

Background

Humana is a major U.S. health insurer; its earnings and guidance are closely watched by investors.

Company-level read

Ticker impact

$HUMBullishHigh confidence
Context

Humana reported Q3 earnings that beat estimates and raised full-year guidance, a primary disclosure for the company.

Expected impact

Potential upside as the raised guidance exceeds consensus, despite a modest post‑announcement dip.

Evidence & confidence

Guidance lift to $9.50 EPS (vs $9.16 consensus) is material for a large‑cap insurer and may attract buying pressure.

Market effects

Sector

May lift sentiment for the health‑insurance sector as earnings beat signals demand strength.

Regional

U.S. insurers could see modest buying pressure in early trading.

Global

Limited to U.S. markets; no immediate global ripple.

Counterpoint

What could challenge this read

The modest 0.8% share dip suggests the market may have already priced in the guidance lift.

Key entities

  • company
    Humana Inc.

    U.S. health insurer reporting Q3 results.

  • executive
    Jim Rechtin

    CEO of Humana, quoted on performance.

Read at source← All news

StoryHumana posts Q3 2026 results and lifts FY2026 adjusted EPS guidance to at least $9.50

Also covered by

6 outlets

Related articles

$HUMHighAI 8/10

Humana Raises Profit Floor on Lower Costs

Humana (HUM) raised its 2026 adjusted earnings guidance to at least $9.50 per share from $9.00, citing lower costs. Q3 insurance benefit ratio was 93.7%, better than expected. Shares fell 0.59% in pre-market trading. Humana's Medicare Advantage membership grew 23% this year.

asktraders.com
$HUMHighAI 8/10

HUM Q3 FY2026 earnings call

Humana Inc. reported Q3 2026 earnings exceeding expectations, raising full-year adjusted EPS guidance to at least $9.50. The company cited favorable medical cost trends and strong execution. Management highlighted progress in clinical quality, Medicaid expansion, and capital allocation, including a divestiture and a new joint venture. Humana expects 2027 Medicare Advantage membership growth and an 8%-9% medical cost trend, with risks and opportunities outlined.

finance.biggo.com
$HUMHighAI 8/10

[Humana Q3 2026 Earnings Call] Humana Lifts Full-Year EPS Guidance to at Least $9.50 as Medical Cost Trend Lands at Low End of 7%-8% Range

Humana Inc. raised its full-year 2026 adjusted EPS guidance to at least $9.50 per share from $9.00, citing favorable medical cost trends. The company reported strong STARS performance and plans to use excess funds for investments and shareholder returns. Humana also announced balance sheet improvements through divestitures and a new joint venture with BlackRock. Management expects 2027 Medicare Advantage membership growth and higher medical cost trends.

finance.biggo.com
$HUMMed

Humana Lifted Its Profit Forecast As Medical Costs Cooled

Humana raised its profit forecast due to lower medical costs, despite posting an adjusted quarterly loss. The company reported a 93.7% medical cost ratio, which may influence its Medicare Advantage pricing. Humana's individual Medicare Advantage membership grew 23% year-to-date, with a target of 25% growth by 2026 and a pretax margin of at least 3% by 2028.

finimize.com